The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica BPC 157 (20mg) Your Peptide Brand The wellness world is eager for RFK Jr.'s promised move on peptides : NPR